Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Human Insulin Market, 2015 - 2021 (USD Billion)

2.2. Global Human Insulin Market: Snapshot

Chapter 3. Human Insulin  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global Human Insulin Market Drivers: Impact Analysis

3.3.2. Rise in Diabetic Patient Population.

3.3.3. Increasing Population Exposure to Key Risk Factors Leading to Diabetes.

3.4. Market Restraints


3.4.1. Global Human Insulin Market Restraints: Impact Analysis

3.4.2. Stringent Regulatory Requirements for Product Approval.

3.5. Opportunities


3.5.1. Emerging Markets

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Type Segment

3.7.2. Market Attractiveness Analysis, By Application Segment

3.7.3. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global Human Insulin Market  Competitive Landscape


4.1. Company Market Share, 2015 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Product And Regional Expansion

4.3. Product Portfolio

4.4. Patent Analysis (2011-2016)


4.4.1. Patent Trend

4.4.2. Patent Share By Company

4.4.3. By Region

Chapter 5. Global Human Insulin Market  Product Segment Analysis


5.1. Global Human Insulin Market: Product Segment Overview


5.1.1. Global Human Insulin Market Revenue Share, By Product Segment, 2015 And 2021

5.2. Drug


5.2.1. Global Human Insulin Market For Drug , 2015  2021 (USD Billion)

5.2.2. Insulin Analogs and Biosimilars


5.2.2.1. Global Human Insulin Market For Insulin Analogs and Biosimilars, 2015  2021 (USD Billion)

5.2.3. Human Insulin Biologics


5.2.3.1. Global Human Insulin Market For Human Insulin Biologics, 2015  2021 (USD Billion)

5.3. Drug Delivery Devices


5.3.1. Global Human Insulin Market For Drug Delivery Devices, 2015  2021 (USD Billion)

5.3.2. Pens


5.3.2.1. Global Human Insulin Market For Pens, 2015  2021 (USD Billion)

5.3.3. Pen Needles


5.3.3.1. Global Human Insulin Market For Pen Needles, 2015  2021 (USD Billion)

5.3.4. Syringes


5.3.4.1. Global Human Insulin Market For Syringes, 2015  2021 (USD Billion)


Chapter 6. Global Human Insulin Market  Application Segment Analysis


6.1. Global Human Insulin Market: Application Segment Overview


6.1.1. Global Human Insulin Market Revenue Share, By Application Segment, 2015 And 2021

6.2. Insulin Dependent Diabetes Mellitus (Type 1)


6.2.1. Global Human Insulin Market For Insulin Dependent Diabetes Mellitus, 2015  2021 (USD Billion)

6.3. Non-Insulin Dependent Diabetes Mellitus (Type 2)


6.3.1. Global Human Insulin Market For Non-Insulin Dependent Diabetes Mellitus, 2015  2021 (USD Billion)

Chapter 7. Global Human Insulin Market  Regional Segment Analysis


7.1. Global Human Insulin Market: Regional Overview


7.1.1. Global Human Insulin Market Revenue Share, By Region, 2015 And 2021

7.1.2. Global Human Insulin Market Revenue Share, By Application, 2015 And 2021

7.2. North America


7.2.1. North America Human Insulin Market Revenue, By Product, 2015  2021 , (USD Billion)

7.2.2. North America Human Insulin Market Revenue, By Application, 2015  2021 , (USD Billion)

7.3. Europe


7.3.1. Europe Human Insulin Market Revenue, By Product, 2015  2021 (USD Billion)

7.3.2. North America Human Insulin Market Revenue, By Application, 2015  2021 , (USD Billion)

7.4. Asia Pacific


7.4.1. Asia Pacific Human Insulin Market Revenue, By Product, 2015  2021 (USD Billion)

7.4.2. North America Human Insulin Market Revenue, By Application, 2015  2021 , (USD Billion)

7.5. Latin America


7.5.1. Latin America Human Insulin Market Revenue, By Product, 2015  2021 (USD Billion)

7.5.2. North America Human Insulin Market Revenue, By Application, 2015  2021 , (USD Billion)

7.6. Middle East And Africa


7.6.1. Middle East And Africa Human Insulin Market Revenue, By Product, 2015  2021 (USD Billion)

7.6.2. North America Human Insulin Market Revenue, By Application, 2015  2021 , (USD Billion)

Chapter 8. Company Profile


8.1. Eli Lilly


8.1.1. Overview

8.1.2. Financials

8.1.3. Type Portfolio

8.1.4. Business Strategy

8.1.5. Recent Developments

8.2. GlaxoSmithCline


8.2.1. Overview

8.2.2. Financials

8.2.3. Type Portfolio

8.2.4. Business Strategy

8.2.5. Recent Developments

8.3. Biocon


8.3.1. Overview

8.3.2. Financials

8.3.3. Type Portfolio

8.3.4. Business Strategy

8.3.5. Recent Developments

8.4. Sanofi Aventis


8.4.1. Overview

8.4.2. Financials

8.4.3. Type Portfolio

8.4.4. Business Strategy

8.4.5. Recent Developments

8.5. Julphar


8.5.1. Overview

8.5.2. Financials

8.5.3. Type Portfolio

8.5.4. Business Strategy

8.5.5. Recent Developments

8.6. Novo Nordisk


8.6.1. Overview

8.6.2. Financials

8.6.3. Type Portfolio

8.6.4. Business Strategy

8.6.5. Recent Developments

8.7. SemBioSys


8.7.1. Overview

8.7.2. Financials

8.7.3. Type Portfolio

8.7.4. Business Strategy

8.7.5. Recent Developments

8.8. Wockhardt


8.8.1. Overview

8.8.2. Financials

8.8.3. Type Portfolio

8.8.4. Business Strategy

8.8.5. Recent Developments

Chapter 9. Patents


9.1. U.S. (US Patents)

9.2. Europe (EP documents)

9.3. Japan (Abstracts of Japan)

9.4. Global (WIPO (PCT))